InvestorLens

ADCT — ADC THERAPEUTICS SA

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ADC THERAPEUTICS SA (ADCT)

ADC THERAPEUTICS SA (ADCT) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $18M. Across recent filings, tracked investors recorded 5 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ADCT

86
/100
Strong Institutional Accumulation
Added / Increased6
Reduced1
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ADCT

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

ADCT Ownership Composition

How ADC THERAPEUTICS SA is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
52% of tracked value
Institutions
3
tracked investors
Total Reported
$26.5M
combined 13F value
Sectors2
  • Other51.7%
  • Hedge Funds48.3%
Other(2)
51.7%
Hedge Funds(1)
48.3%

Tracked investors reporting ADCT

  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    3.4M
    Value
    $12.8M
    % Portfolio
    0.02%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    3.3M
    Value
    $12.2M
    % Portfolio
    0.01%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    399.7K
    Value
    $1.5M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold ADCT?
3 tracked institutional investors disclosed a position in ADCT (ADC THERAPEUTICS SA) in their most recent 13F filing.
Who is the largest institutional holder of ADCT?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ADCT, valued at $18M.
Did institutional ownership of ADCT increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 1 increased, 1 reduced, and 0 fully exited ADCT.
Where does this ADCT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.